Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2003, p. 1023-1032, Vol. 41, No. 3
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.3.1023-1032.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Daniel W. Isenbarger,1,
and Luther E. Lindler2
Department of Enteric Infections,1 Department of Bacterial Diseases, Walter Reed Army Institute of Research, Silver Spring, Maryland 209102
Received 6 May 2002/ Returned for modification 6 September 2002/ Accepted 17 December 2002
|
|
|---|
|
|
|---|
Tetracyclines have been used extensively since the late 1940s as broad-spectrum inexpensive antibiotics that are effective against a wide variety of diseases in humans, animals, and plants. However, resistance to tetracycline has increased dramatically since the first appearance of resistance in 1953 in S. dysenteriae (6). The transmissibility of resistance in bacterial populations can take place by either clonal spread of particular strains or horizontal transfer of resistance determinants by plasmid- or transposon-mediated conjugation (2). Most tetracycline resistance determinants, defined as genetic units which contain both structural and regulatory genes involved in resistance (18), have been found on resistance plasmids or transposons, making gene transfer the likely method of acquiring resistance. The mechanisms of resistance have been well characterized, and the proteins have been classified into those that affect the energy-dependent efflux of tetracycline or allow ribosomal protection from its action (6). The classes of resistance determinants have been identified on the basis of DNA-DNA hybridization using structural genes as probes under stringent conditions (
80% sequence identity) and in many cases subsequent DNA sequencing (6). Tetracycline efflux resistance determinants belonging to classes A to E, G, and H have been described in gram-negative bacteria, with classes A to E and G found in gram-negative enteric bacteria and class H found in species of Pasteurella and Mannheimia, which infect food-producing animals (6, 12). Molecular techniques such as PCR assays that identify the Tet resistance determinants are a valuable tool for epidemiological studies of resistance, providing important epidemiological information about the transmission of these genes through bacterial populations and the geographical and temporal spread of particular clones and allowing discrimination between clonal spread and horizontal transfer of resistance determinants (1, 5, 8, 11, 16, 30). Recent studies on gram-negative bacteria have examined the distribution of specific Tet determinants using genotypic detection assays (3, 5, 7, 11, 16, 21, 22, 27). However, only one paper (22), which included only 33 strains isolated in Mexico City, Mexico, in 1978 to 1979, has studied the distribution of these determinants in Shigella spp.
A more comprehensive study of Tet determinants in this genus was an important goal of this study, which focused on examining by PCR analysis the distribution of Tet determinants in 459 serotyped Shigella and enteroinvasive Escherichia coli (EIEC) clinical isolates (the latter of which show the same invasive phenotype characteristic of shigellae) from several geographical locations in four continents and in countries in various stages of development. The objectives of this study were (i) to examine the geographical and species-specific distribution of Tet determinants in these clinical isolates and (ii) to determine if the distribution of the determinants is due to clonal spread and/or horizontal transfer. Detection of horizontal gene transfer usually requires detection of an identical or unique marker in different species. During these studies, an allele of tet(A), designated tet(A)-1, was identified, and the plasmid containing it (pSSTA-1) was characterized. These two markers were then used as epidemiological tools to track the clonal and horizontal transmission of determinant Tet A-1.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Origin, source, and species of strains used in this study
|
PCR reagents, conditions, and primers. Tet determinants of classes A to E, G, and H were detected by PCR analysis (GeneAmp PCR system 9600; PE Biosystems, Foster City, Calif.) with primers made on a 394 DNA/RNA Synthesizer (PE Biosystems). Primers were either designed based on sequences available from GenBank using the Primerselect software program (Lasergene, Madison, Wis.) or were obtained from published primer sequences as shown in Table 2. Expected amplicon size and control strains are also indicated. There are three reverse primers to differentiate tet(A) and tet(A)-1: (i) Tet AR (CTG CCT GGA CAA CAT TGC TT), which amplifies both genes (10); (ii) Tet AR2 (GTG CAA CGG GAA TTT GAA G), which amplifies only tet(A)-1 (derived from accession number AJ307714 and AF502943); and (iii) Tet AR3 (GGC ATA GGC CTA TCG TTT CCA), which amplifies only the tet(A) gene found in Tn1721 (X61367). Additional primers used for identifying resistance genes on the resistance plasmid containing Tet A-1 were (i) sul1, 5'-CAT CAT GAA ACG GAT CAC CG-3'; (ii) sul2. 5'-AGC GCC GCC AAT ACC GCC AG-3'; (iii) sul3, 5'-GCG CTC ACA GGC CGT GGT CC-3'; (iv) str1, 5'-TGA CTG GTT GCC TGT CAG AGG-3'; (v) str2, 5'-CCA GTT CTC TTC GGC GTT AGC A-3'; (vi) str3, 5'-CGC CTG TTT TTC CTG CTC AT-3'; (vii) str4, 5'-CCA TCC GCG TTC CAA GCT GC-3'); (viii) aadA, 5'-ACC TTT TGG AAA CTT CGG CT; and (ix) aadArev, 5'-TTT CAT CAA GCT TTA CGG TCA CCG-3'. These primers were derived from sequences found in accession numbers AB076707 (Salmonella enterica subsp. enterica serovar Choleraesuis cryptic plasmid for primers sul1, sul2, and sul3), M28829 and reference 28 (plasmid RSF1010 for primers str1, str2, str3, and str4), and X12870 and reference 25 (transposon Tn21 aadA-sul1 region for primers aadA and aadArev). Templates for PCR analysis were prepared by spinning down 1-ml overnight cultures, resuspending the pellet in 300 µl of sterile distilled water, boiling for 10 min, and centrifuging the sample for 2 min to pellet debris. For a 25-µl PCR mixture, 2 µl of the supernatant was used. The reaction mixture included 2.5 µl of 10x PCR buffer (Life Technologies, Grand Island, N.Y.), 0.75 µl of 50 mM MgCl2, 0.5 µl of 10 mM deoxytriphosphates mix (Roche Molecular Biochemicals, Indianapolis, Ind.), and 0.25 µl of Taq DNA polymerase (Life Technologies) at 5 U/µl. Reactions were performed in a Perkin-Elmer GeneAmp PCR system 9600 using the cycling parameters of an original denaturation step of 94°C for 1 min; followed by 25 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s; and ending with a cycle of 72°C for 5 min. Reaction products were analyzed by gel electrophoresis on 0.8% agarose gels using 0.5x Tris-borate-EDTA buffer.
|
View this table: [in a new window] |
TABLE 2. PCR primers used in identification of tetracycline resistance determinants
|
/pVM111, Tet H.
Plasmid manipulations.
Plasmid purification of overnight 5-ml cultures of Shigella strains was done using miniprep kits (Qiagen, Inc., Santa Clarita, Calif.). Presence of plasmid DNA was confirmed by agarose gel electrophoresis. An aliquot of these preparations was then electroporated into E. coli DH5
and plated on tetracycline-Luria broth agar plates to isolate plasmids conferring tetracycline resistance. Restriction endonuclease analysis of plasmid DNA isolated from these clones using Qiagen midiprep kits was performed using 0.8% agarose gel electrophoresis.
DNA sequencing analysis. DNA sequence analysis was used to confirm the sequence of Tet A-1 and to confirm the identification of the Tet D determinants present in some of the isolates (see Results). One to two other PCR products were amplified from strains containing Tet A, B, and C using the class-specific primers described above and partially sequenced to verify identification. Tet D determinants were amplified and sequenced using primers based on GenBank accession number L06798. The plasmid harboring Tet A-1, designated pSSTA-1, was purified from S. sonnei strain SPH-1482, a clinical isolate from Thailand, and a 4.67-kb BglII-KpnI fragment containing Tet A-1, which includes structural gene tet(A)-1 and regulatory gene tetR(A), was cloned into pUC18 (pTA-1). Initial sequencing used the M13 forward and reverse universal primers. Further sequencing of both strands of Tet A-1 was performed with primers based on a previously reported Tet A sequence (AJ307714). The Primerselect software program (Lasergene) was used for all oligonucleotide design during sequencing experiments. Nucleotide sequence determination was performed by the dideoxychain termination method using the Applied Biosystems International (Foster City, Calif.) PRISM dichloRhodamine Dye Terminator sequencing kit with AmpliTaq DNA polymerase. DNA sequencing reactions were analyzed on an Applied Biosystems International 377XL automated DNA sequencer. Sequence data were edited and assembled into contiguous sequences using Seqman (Lasergene).
Nucleotide sequence accession numbers. The Tet D sequences have been deposited in GenBank and assigned accession numbers AF467071 to AF467078. The Tet A-1 sequence of S. sonnei strain SPH-1482 has been deposited in GenBank (AF502943).
|
|
|---|
Identification of tetracycline resistance determinants by PCR analysis. PCR primers specific for tetracycline resistance determinants A to E, G, and H were designed to give PCR products from the positive control strains. Amplification products using these primers with the control strains and a negative control strain (sensitive to tetracycline) are shown in Fig. 1A and B. Primers were also tested against control strains positive for the other determinants to eliminate the chance of cross-reactivity (data not shown). These primers were then used to screen the tetracycline-resistant isolates for the presence of these determinants. Only primers for classes A to D gave products when the clinical isolates were screened. PCR products from four to five samples of tetracycline classes A to D were probed with radiolabeled DNA amplified from control strains of Tet determinants A to D. These results confirmed the Tet identification in all cases, and there was no indication of nonspecific amplification of the determinants (data not shown).
![]() View larger version (72K): [in a new window] |
FIG.1. PCR products of tetracycline resistance determinants A to E, G, and H from positive and negative control strains and clinical isolates. Primers and positive control strains used are shown in Table 2. Negative control strains used were the tetracycline-sensitive strain S. sonneiSPH-2274 (A and B) and the tetracycline-sensitive strain S. flexneri serotype 6 SPH-1484 (C), both from Thailand. PCR analysis was done as described in Materials and Methods, and products were viewed using 0.8% agarose gel electrophoresis. (A) Lane M, molecular weight markers; lane 1, S. sonnei strain SPH-1482 (Tet A-1); lane 2, S. flexneri X strain SPH-810 (Tet A); lane 3, S. flexneri X strain SPH-1466 (Tet A); lane 4, S. sonnei strain SPH-788 (Tet A-1); lane 5, SPH-2274; lane 6, SPH-1482; lane 7, SPH-810; lane 8, SPH-1466; lane 9, SPH-788; lane 10, SPH-2274; lane 11, S. flexneri 1 strain NIH 1220; lane 12, S. dysenteriae 1 strain SPH-1351; lane 13, S. dysenteriae 1 strain SPH-1350C3; lane 14, S. flexneri 1 strain vn-41; lane 15, SPH-2274. Tet A primers Tet AF and Tet AR (lanes 1 to 5), Tet A primers Tet AF and Tet AR2 (lanes 6 to 10), and Tet B primers Tet BF and Tet BR (lanes 11 to 15) were used. (B) Lane M, molecular weight markers; lane 1, pBR322; lane 2, EIEC strain SPH-165321; lane 3, S. flexneri strain vn-nb7; lane 4, SPH-2274; lane 5, pSL106; lane 6, S. sonnei strain AS-14; lane 7, S. sonnei strain SPH-788; lane 8, SPH-2274; lane 9, pSL1504; lane 10, SPH-2274; lane 11, pJA8122; lane 12, SPH-2274; lane 13, pVM112H; lane 14, SPH-2274. Tet C primers Tet CF and Tet CR (lanes 1 to 4), Tet D primers Tet DF and Tet DR (lanes 5 to 8), Tet E primers Tet EF and Tet ER (lanes 9 and 10), Tet G primers Tet GF and Tet GR (lanes 11 and 12), and Tet H primers Tet HF and Tet HR (lanes 13 and 14) were used. (C) Lane M, molecular weight markers; lane 1, S. flexneri X strain SPH-810 (Tet A); lane 2, EIEC strain SPH-2148-1 (Tet A); lane 3, S. sonnei strain WS007980 (Tet A-1); lane 4, S. sonnei strain SPH-2357A4 (Tet A-1); lane 5, SPH-1484, all with Tet AF and Tet AR primers. Lanes 6 to 10 show the same strains using Tet AF and Tet AR3 primers. Only the strains with the Tn1721 Tet A (lanes 6 and 7) have a PCR product. Lanes 11 to 15 show the same strains using Tet AF and Tet AR2 primers. Only the strains containing Tet A-1 (lanes 13 and 14) have a PCR product.
|
Resistance determinants by species and locality. Distribution of Tet determinants in the 459 tetracycline-resistant isolates was first analyzed by species as shown in Fig. 2. Some percentages add up to more than 100% due to the presence of two determinants (see below). This is particularly true of S. sonnei in which 41% of the isolates contained both Tet A-1 and Tet D. These results represent Tet determinant distribution from all localities and time periods. Only Tet determinants of classes A to D and A-1 were found in the clinical isolates. It is apparent from these results that Tet B, which is the only efflux resistance determinant identified so far that confers resistance to minocycline as well as tetracycline, is the predominant tetracycline resistance determinant in shigellae and EIEC, with Tet A being the second most predominant. There was variation in the distribution of other determinants in the species. Only 8 of the 459 resistant strains (1.7%) contained the Tet C determinant, and 63% of these were EIEC strains, the only group with a notable percentage (25%) of Tet C. Both S. boydii (8 of 24 tetracycline-resistant strains) and EIEC (6 of 20 resistant strains) had a significant percentage of Tet A. In contrast, S. flexneri and S. dysenteriae were distinctive in the predominance (74 and 85%, respectively) of Tet B compared to the presence of Tet A (26 and 12%, respectively). S. sonnei had a unique distribution of tetracycline determinants, with Tet A-1 and Tet D being the predominant determinants. However, there is a locality difference in Tet distribution in S. sonnei as is shown in Table 3. When the determinants of S. sonnei from Thailand and Vietnam were compared, it was apparent that although Tet B was predominant in S. sonnei strains from Vietnam, Tet D and Tet A-1 were predominant in the specimens isolated from Thailand, and these determinants were found together in 93% of these isolates.
![]() View larger version (31K): [in a new window] |
FIG. 2. Distribution of tetracycline resistance determinants by species. The percentages of tetracycline resistance determinants Tet A to D and Tet A-1 determinants are shown as distributed by species. Percentages of each determinant are indicated for each species
|
|
View this table: [in a new window] |
TABLE 3. Comparison of Tet determinant distribution in S. flexneri strains and S. sonnei strains from different geographical locations
|
Strains with two tetracycline resistance determinants. Most Shigella strains contained only one Tet determinant. However, 9 of the 459 strains (2%) were positive for both Tet A and Tet B. Seven of these strains (five S. sonnei strains and two S. flexneri strains) were from Vietnam. One EIEC strain from Thailand had both Tet A and Tet D. The most significant numbers of strains with two determinants were the 25 S. sonnei strains and one S. dysenteriae strain from Thailand as well as one S. dysenteriae strain from Somalia that were positive for both Tet A-1 and Tet D. To confirm that these clinical isolates contained both determinants, the Tet D determinants from nine different isolates were sequenced, and the sequences were found to be identical to the GenBank entries for Tet D (L06798 and X65876). The Tet D determinant in these isolates was difficult to detect after subculture of the isolates. Whether this is due to instability of a plasmid or genetic element containing the gene or to masking of the gene by another determinant (Tet A or Tet A-1) is not known. Sequencing of Tet A-1 from three different isolates containing both genes also confirmed its presence. The presence of Tet A-1 was also confirmed using the Tet AF primer with Tet AR2 and Tet AR3 as shown in Fig. 1C. Since there was one EIEC strain that contained Tet D and the Tn1721-like Tet A determinant and eight strains from various localities that contained only Tet A-1, the Tet D determinant is likely located on a different genetic element than either Tet A or Tet A-1.
Characterization of pSSTA-1. The plasmid containing the Tet A-1 determinant, designated pSSTA-1, was isolated from S. sonnei strain SPH-1482 from Thailand and characterized. The restriction map of the 8.6-kb plasmid is shown in Fig. 3A. The Tet A-1 determinant was located on the 4.67-kb KpnI-BglII fragment. This entire fragment was cloned into pUC18 (pTA-1) and sequenced, revealing the variation in the last 28 nucleotides of the coding region of tet(A)-1 as well as in the 3' flanking region. A GenBank search using the BLAST system (http://www3.ncbi.nlm.nih.gov/) revealed that this region was >99% homologous at the DNA level to portions of a cryptic plasmid from S. enterica subsp. enterica serovar Choleraesuis (accession number AB076707). The probable recombination site is shown in Fig. 3B. Note that at this site, both tet(A) and the Salmonella sequence contain the sequence TTGGAG. The 307-bp region 3' to the TTGGAG in tet(A)-1 is also homologous to part of a putative transposase found in an E. coli plasmid encoding florfenicol resistance (AF231986), a Vibrio cholerae antibiotic resistance cluster (AY034138), and the sequence 3' to the strB gene in plasmid RSF1010 (M28829). The rest of the coding region of tet(A)-1 and the sequence of tetR(A) located on pSSTA-1 are >99% homologous to the Tet A sequence found in Tn1721. pSSTA-1 also conferred resistance to streptomycin and trimethoprim (a sulfonamide), while pTA-1 only conferred tetracycline resistance, indicating that the other resistance genes were located on the 3.9-kb KpnI-BglII fragment. This fragment was cloned into pUC18 (pSTSU), mapped by restriction endonuclease analysis, and tested with primers specific for sulfonamide and streptomycin resistance genes to identify the other resistance genes found on pSSTA-1 (Materials and Methods). PCR products were obtained with sul1 and sul2, str1 and str2, str3 and str4, str1 and str4, sul3 and str2, and sul3 and str4, indicating that pSSTA-1 also contains sulII, strA, and strB. The genetic organization of this region is shown in Fig. 3C. This region is identical in organization to that found in plasmid RSF1010 (M28829), a broad-host-range plasmid found in many gram-negative enteric bacteria (28).
![]() ![]() ![]() View larger version (38K): [in a new window] |
FIG. 3. Characterization of pSSTA-1, the 8.6-kb plasmid containing Tet A-1. (A) Restriction map of pSSTA-1. Restriction endonucleases are abbreviated as follows: Bg, BglII; E, EcoRI; Ev, EcoRV; Hp, HpaI; K, KpnI; S, SalI; Sc, SacI. Positions of the sulII, strA, and strB genes and the tetR(A) and tet(A)-1 genes are indicated. (B) Schematic presentation of the 4.67-kb KpnI-BglII fragment containing Tet A-1. This entire fragment was sequenced. The positions of genes tetR(A) and tet(A)-1 and the likely site of recombination with the tet(A) gene present in Tn1721 and the Salmonella cryptic plasmid are shown. Amino acids for Tet(A) and Tet(A)-1 in the recombination region are given. The six homologous nucleotides found in tet(A), tet(A)-1, and the Salmonella plasmid are underlined. (C) Schematic presentation of the 3.9-kb KpnI-BglII fragment containing the streptomycin and sulfonamide resistance genes. Locations of primers specific for sulII, strA, and strB used to identify the presence of these genes and map the resistance region are shown. The genetic organization of this region is identical to that of broad-host-range plasmid RSF1010.
|
|
View this table: [in a new window] |
TABLE 4. Strains containing Tet A-1 and probable mode of transmission
|
|
|
|---|
The study reported here examined the distribution of tetracycline determinants in 459 tetracycline-resistant clinical isolates of all four species of shigellae and EIEC from several different geographical locations and from countries in differing stages of development. Using primers specific for Tet A to E, G, and H in PCR analysis, it was established that Tet B was the predominant tetracycline resistance determinant in shigellae in all serogroups examined in this study and that only Tet determinants A, B, C, and D were represented in the 459 strains. Although Tet B was found to be the predominant determinant in the Shigella genus in both this study and the 1986 report, the results of this study differed from those of the 1986 work in the species distribution of the Tet determinants. For example, only 2 of the 64 S. sonnei isolates and none of the S. flexneri isolates contained Tet C, in contrast to the results of the earlier study. In the present study, only EIEC had a significant percentage of Tet C. Because of the large number of isolates from different locations in this study, it was possible to note both species and locality differences in tetracycline resistance distribution. This was particularly apparent in the difference in Tet determinant distribution in the S. sonnei isolates from Thailand and Vietnam. As was found in previous studies, there were very few cases where two resistance genes were found in one strain (8.2% of the strains examined) except for the Thailand S. sonnei strains. This may be the result of incompatibility of different resistance plasmids, as has been mentioned previously (6, 14).
This study demonstrated that both clonal spread and horizontal transmission have occurred in the dissemination of Tet determinants in shigellae. Clonal spread was most evident in the S. sonnei strains from Thailand, where all of the isolates either contained Tet A-1 and Tet D or Tet A-1 alone, and in the S. flexneri X strains from Thailand. Since S. sonnei has only one serotype, the identification of distinguishing epidemiological markers such as Tet A-1 is helpful in tracing clonal relationships. The presence of Tet A-1 and pSSTA-1 proved to be useful epidemiological markers for following transmission of resistance determinants and establishing horizontal transfer between species. Tet A-1 was found in a variety of serogroups from different geographical locations, suggesting the occurrence of horizontal transfer of this allele between species. PCR analysis and/or restriction analysis was used to identify the presence of pSSTA-1 in 15 other strains containing Tet A-1, thus making it possible to track the transmission of Tet A-1 and the transfer of the plasmid among different species and to determine that pSSTA-1-like plasmids were found in Shigella at least as early as 1983. However, from these results, it cannot be determined whether Tet A-1 and pSTA-1 originated in Shigella or in another genera of the Enterobacteriaceae.
The homology of pSSTA-1 to regions of the Salmonella cryptic plasmid including a portion of a putative transposase 3' to the probable site of recombination indicates that an illegitimate recombination may have occurred to produce the Tet A-1 determinant. A recent publication (9) found that integration sites of foreign DNA into the genome of Acinetobacter species contained short stretches of sequence identity (3 to 8 bp) between donor and recipient DNA, indicating that illegitimate recombination is facilitated when homologous DNA is present. There are six homologous nucleotides (TTGGAG) at the likely site of recombination between Tet A from Tn1721 and the Salmonella cryptic plasmid. These same six nucleotides are also found after the strB gene and 5' to the 307-bp putative transposase in RSF1010, suggesting that other recombinations may have occurred in the origin of pSSTA-1 to form the sulII-strA-strB region. Although the exact origin of pSSTA-1 is not known, the presence of a Salmonella cryptic plasmid in Shigella species demonstrates plasmid transfer between genera.
The four countries in this study with more than 35 isolates of various serogroups have differences in degree of development. Thailand is relatively developed and urban, while rural Bangladesh is considered a least-developed country by the United Nations. Vietnam and Egypt are intermediate between these two countries. In more-developed countries, S. sonnei is more prevalent and clonal spread of infection is the normal method of transmission (15). Certainly this was true in Thailand, where it was apparent from this study that 93% of the tetracycline-resistant S. sonnei strains were clonally related. In Bangladesh, no S. sonnei strains were isolated. In Vietnam, there were 27 S. sonnei tetracycline-resistant strains compared to 146 tetracycline-resistant S. flexneri strains. The distribution of Tet determinants in S. sonnei in Vietnam was quite different from that in Thailand, and there was only a limited suggestion of clonality. In Egypt, there were only four resistant S. sonnei strains compared to 13 resistant S. flexneri strains, but they all contained Tet A-1 and appeared to be clonally related. These observations suggest that the epidemiological monitoring of antibiotic resistance spread may lend new insights into the mechanisms of dissemination of these determinants that may be related to environmental factors such as the development of the region.
In summary, this work presents the first comprehensive study of Tet determinant distribution in the genus Shigella, using a large number of clinical isolates from a variety of geographical locations. The use of Tet determinant identification in epidemiological analysis of clonal spread and resistance transmission among species and strains was demonstrated. In addition, the usefulness in epidemiological studies of the identification of specific markers such as the Tet A-1 determinant and pSSTA-1 was shown. The impact that environment and regional development have on movement of these determinants will be the subject of future investigations.
Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army.
Present address: Department of Microbiology and Tropical Medicine, The George Washington University, Washington, DC 20037. ![]()
Present address: Division of Cardiology, Department of Medicine, Walter Reed Army Medical Center, Washington, DC 20307. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»